The Fermentation Facility at Waksman Institute has a multi-client base and produces a wide range of bulk biologics including: antimicrobials, cosmetic substrates, flavors/fragrances, biopesticides/bioherbicides and plasmid-derived proteins, enzymes, growth factors and diagnostics to name just a few. We are equipped to handle most requests with the exceptions: pathogenic or opportunistic organisms and mammalian and insect cell lines. The facility is designated BL2-LS. Our bioreactor volumes range from 32 to 800L maximum operating volumes. All projects are conducted under CDA/NDA agreements, which limit discussion of specific company or projects. We operate as a not-for-profit, fee-for-service, self-supportive lab and receive no direct funding from state or federal sources.